Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026465
Filing Date
2024-11-08
Accepted
2024-11-08 17:24:43
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 form4-11082024_101140.html 4  
1 form4-11082024_101140.xml 4 7088
  Complete submission text file 0001415889-24-026465.txt   8503
Mailing Address C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730
Business Address
PETERS WILLIAM J (Reporting) CIK: 0001263136 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 241441931

Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)